ProQR Therapeutics (PRQR) Goodwill & Intangibles (2013 - 2018)
ProQR Therapeutics (PRQR) posted Goodwill & Intangibles of -$218006.7 for Q4 2018, down 480692.87% sequentially from $45.36 in Q3 2018, and down 574.75% YoY from $45919.9 in Q4 2017.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Goodwill & Intangibles (2013 - 2018) Analysis & Trends
ProQR Therapeutics has reported Goodwill & Intangibles for 6 years, with the latest figure at -$218006.7 in Q4 2018.
- Quarterly Goodwill & Intangibles fell 574.75% year-over-year to -$218006.7 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$218006.7 (down 574.75% YoY) and the FY2018 annual result came in at -$218006.7, down 574.75% from the prior year.
- Goodwill & Intangibles fell to -$218006.7 in Q4 2018 per PRQR's latest filing, from $45.36 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $203722.9 in Q4 2014 and troughed at -$218006.7 in Q4 2018.
- A 5-year average of $50328.7 and a median of $46544.3 in 2018 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2014 and 2018: Goodwill & Intangibles surged 283.79% in 2014, then tumbled 574.75% in 2018.
- Over 5 years, Goodwill & Intangibles stood at $203722.9 in 2014, then decreased by 24.14% to $154552.5 in 2015, then slumped by 37.12% to $97175.2 in 2016, then plunged by 52.75% to $45919.9 in 2017, then sank by 574.75% to -$218006.7 in 2018.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered -$218006.7, $45.36, and $46544.3 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 218,006.72 |
| Sep 30, 2018 | 45.36 |
| Jun 30, 2018 | 46,544.33 |
| Mar 31, 2018 | 47,912.78 |
| Dec 31, 2017 | 45,919.87 |
| Sep 30, 2017 | 61,103.29 |
| Jun 30, 2017 | 71,470.71 |
| Mar 31, 2017 | 83,101.74 |
| Dec 31, 2016 | 97,175.18 |
| Sep 30, 2016 | 114,967.00 |
| Jun 30, 2016 | 131,065.50 |
| Mar 31, 2016 | 141,185.56 |
| Dec 31, 2015 | 154,552.54 |
| Sep 30, 2015 | 170,179.59 |
| Jun 30, 2015 | 183,453.45 |
| Mar 31, 2015 | 171,734.54 |
| Dec 31, 2014 | 203,722.86 |
| Sep 30, 2014 | 51,764.37 |
| Dec 31, 2013 | 53,082.49 |